An assessment system for clinical and biological interpretability in ulcerative colitis

被引:0
作者
Zhang, Shiqian [1 ]
Zhang, Ge [2 ,3 ]
Wang, Wenxiu [4 ]
Guo, Song-Bin [5 ,6 ]
Zhang, Pengpeng [7 ]
Wang, Fuqi [1 ]
Zhou, Quanbo [1 ]
Zhou, Zhaokai [8 ]
Wang, Yujia [2 ,3 ]
Sun, Haifeng [1 ]
Cui, Wenming [1 ]
Yang, Shuaixi [1 ]
Yuan, Weitang [1 ]
机构
[1] Zhengzhou Univ, Affiliated Hosp 1, Dept Colorectal Surg, Zhengzhou 450052, Henan, Peoples R China
[2] Zhengzhou Univ, Affiliated Hosp 1, Dept Cardiol, Zhengzhou 450052, Henan, Peoples R China
[3] Henan Prov Clin Res Ctr Cardiovasc Dis, Zhengzhou 450052, Henan, Peoples R China
[4] Zhengzhou Univ, Affiliated Hosp 3, Dept Neonatol, Zhengzhou 450052, Henan, Peoples R China
[5] Sun Yat Sen Univ, Canc Ctr, Dept Med Oncol, Guangzhou 510060, Guangdong, Peoples R China
[6] Sun Yat Sen Univ, Canc Ctr, Collaborat Innovat Ctr Canc Med, State Key Lab Oncol South China, Guangzhou 510060, Guangdong, Peoples R China
[7] Nanjing Med Univ, Affiliated Hosp 1, Dept Thorac Surg, Nanjing 210029, Jiangsu, Peoples R China
[8] Zhengzhou Univ, Affiliated Hosp 1, Dept Urol, Zhengzhou 450052, Henan, Peoples R China
来源
AGING-US | 2024年 / 16卷 / 04期
基金
中国国家自然科学基金;
关键词
machine learning; diagnosis model; regulatory landscape; computational biology; biological interpretability; INFLAMMATORY-BOWEL-DISEASE; RANDOM FOREST; EXPRESSION; DIAGNOSIS; CLASSIFICATION; MECHANISMS;
D O I
暂无
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Ulcerative colitis (UC) is a serious inflammatory bowel disease (IBD) with high morbidity and mortality worldwide. As the traditional diagnostic techniques have various limitations in the practice and diagnosis of early ulcerative colitis, it is necessary to develop new diagnostic models from molecular biology to supplement the existing methods. In this study, we developed a machine learning -based synthesis to construct an artificial intelligence diagnostic model for ulcerative colitis, and the correctness of the model is verified using an external independent dataset. According to the significantly expressed genes related to the occurrence of UC in the model, an unsupervised quantitative ulcerative colitis related score (UCRScore) based on principal coordinate analysis was established. The UCRScore is not only highly generalizable across UC bulk cohorts at different stages, but also highly generalizable across single-cell datasets, with the same effect in terms of cell numbers, activation pathways and mechanisms. As an important role of screening genes in disease occurrence, based on connectivity map analysis, 5 potential targeting molecular compounds were identified, which can be used as an additional supplement to the therapeutic of UC. Overall, this study provides a potential tool for differential diagnosis and assessment of bio-pathological changes in UC at the macroscopic level, providing an opportunity to optimize the diagnosis and treatment of UC.
引用
收藏
页码:3856 / 3879
页数:24
相关论文
共 50 条
  • [41] Pharmacodynamic assessment of vedolizumab for the treatment of ulcerative colitis
    McLean, Leon P.
    Cross, Raymond K.
    EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY, 2016, 12 (07) : 833 - 842
  • [42] Assessment of disease activity in pediatric ulcerative colitis
    Kolho, Kaija-Leena
    EXPERT REVIEW OF GASTROENTEROLOGY & HEPATOLOGY, 2016, 10 (10) : 1127 - 1134
  • [43] Assessment of Endoscopic Mucosal Healing of Ulcerative Colitis Using Linked Colour Imaging, a Novel Endoscopic Enhancement System
    Uchiyama, Kazuhiko
    Takagi, Tomohisa
    Kashiwagi, Saori
    Toyokawa, Yuki
    Tanaka, Makoto
    Hotta, Yuma
    Dohi, Osamu
    Okayama, Tetsuya
    Yoshida, Naohisa
    Katada, Kazuhiro
    Kamada, Kazuhiro
    Ishikawa, Takeshi
    Handa, Osamu
    Konishi, Hideyuki
    Kishimoto, Mitsuo
    Yagi, Nobuaki
    Naito, Yuji
    Itoh, Yoshito
    JOURNAL OF CROHNS & COLITIS, 2017, 11 (08) : 963 - 969
  • [44] Optimizing individualized management of patients with ulcerative colitis: Identification of risk factors predicting ulcerative colitis-associated neoplasia
    Jiang, Wenyu
    Lu, Meijiao
    Zhang, Li
    Xu, Chenjing
    Wang, Ruohan
    Xu, Ying
    Tang, Wen
    Zhang, Hongjie
    MEDICINE, 2023, 102 (32) : E34729
  • [45] Genetics and Ulcerative Colitis: What are the Clinical Implications?
    Latiano, Anna
    Annese, Vito
    CURRENT DRUG TARGETS, 2011, 12 (10) : 1383 - 1389
  • [46] Clinical characteristics of ulcerative colitis in elderly patients
    Zhu, Mingming
    Ran, Zhihua
    JGH OPEN, 2021, 5 (08): : 849 - 854
  • [47] Clinical Characteristics of Idiopathic Ulcerative Colitis in Children
    Lekovic, Zoran
    Radlovic, Nedeljko
    Brdar, Radivoj
    Vuletic, Biljana
    Janic, Nenad
    Ristic, Dragana
    Stojsic, Zorica
    Radlovic, Vladimir
    Simic, Dusica
    Nikolic, Dejan
    SRPSKI ARHIV ZA CELOKUPNO LEKARSTVO, 2011, 139 (3-4) : 170 - 173
  • [48] ACG Clinical Guideline: Ulcerative Colitis in Adults
    Rubin, David T.
    Ananthakrishnan, Ashwin N.
    Siegel, Corey A.
    Sauer, Bryan G.
    Long, Millie D.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2019, 114 (03) : 384 - 413
  • [49] Ulcerative Colitis Severity Classification and Localized Extent (UC-SCALE): An Artificial Intelligence Scoring System for a Spatial Assessment of Disease Severity in Ulcerative Colitis
    Gutierrez-Becker, Benjamin
    Fraessle, Stefan
    Yao, Heming
    Luscher, Jerome
    Girycki, Rafal
    Machura, Bartosz
    Czornik, Janusz
    Goslinsky, Jaroslaw
    Pitura, Marek
    Levitte, Steven
    Arus-Pous, Josep
    Fisher, Emily
    Bojic, Daniela
    Richmond, David
    Bigorgne, Amelie E.
    Prunotto, Marco
    JOURNAL OF CROHNS & COLITIS, 2025, 19 (01)
  • [50] Safety and tolerability of spesolimab in patients with ulcerative colitis
    Ferrante, Marc
    Irving, Peter M.
    Selinger, Christian P.
    D'Haens, Geert
    Kuehbacher, Tanja
    Seidler, Ursula
    Gropper, Savion
    Haeufel, Thomas
    Forgia, Sebastiano
    Danese, Silvio
    Klaus, Jochen
    Feagan, Brian G.
    EXPERT OPINION ON DRUG SAFETY, 2023, 22 (02) : 141 - 152